CWM
REGN icon

Cabot Wealth Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Cabot Wealth Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-8,112
Closed -$3.26M – 153
2016
Q3 		$3.26M Sell
8,112
-234
-3% -$93.9K 0.84% 45
2016
Q2 		$2.92M Sell
8,346
-180
-2% -$69.3K 0.77% 49
2016
Q1 		$3.07M Sell
8,526
-320
-4% -$132K 0.86% 50
2015
Q4 		$4.8M Sell
8,846
-108
-1% -$58.5K 1.23% 26
2015
Q3 		$4.17M Buy
8,954
+296
+3% +$159K 1.15% 31
2015
Q2 		$4.42M Buy
8,658
+48
+0.6% +$23.4K 1.07% 38
2015
Q1 		$3.89M Sell
8,610
-179
-2% -$75.9K 0.95% 45
2014
Q4 		$3.61M Sell
8,789
-174
-2% -$68.4K 0.89% 54
2014
Q3 		$3.23M Hold
8,963
– – 0.83% 58
2014
Q2 		$2.53M Sell
8,963
-88
-1% -$26.1K 0.64% 74
2014
Q1 		$2.72M Buy
9,051
+4,247
+88% +$1.31M 0.71% 63
2013
Q4 		$1.32M Buy
+4,804
New +$1.38M 0.35% 100

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Cabot Wealth Management's REGN Position: Q4 2016 in Review

Cabot Wealth Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2016, closing a stake of 8,112 shares — an estimated $3.26M sold.

Cabot Wealth Management first reported a position in REGN in Q4 2013 and held it in 12 quarters. The position peaked at $4.8M in Q4 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2016.

  • Cabot Wealth Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Cabot Wealth Management sold 8,112 Regeneron Pharmaceuticals shares in Q4 2016, an estimated $3.26M.
  • Cabot Wealth Management first reported a position in Regeneron Pharmaceuticals in Q4 2013 and held it in 12 quarters.
  • Cabot Wealth Management's Regeneron Pharmaceuticals position peaked at $4.8M in Q4 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2016.

Based on Cabot Wealth Management's 13F filing for Q4 2016, filed 7 Feb 2017.